GO:0003908 methylated-DNA-[protein]-cysteine S-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003908 describes the catalytic activity that removes a methyl group from O6-methylguanine in DNA and transfers it to a cysteine residue in the enzyme itself, a direct reversal repair reaction.
• The reaction is suicidal: the methyltransferase is inactivated after a single methyl transfer, so activity depends on de novo protein synthesis and protein stability.
• Phosphorylation of the methyltransferase at serine-204 significantly increases its resistance to proteolytic digestion, linking post-translational modification to repair capacity.
• The activity is encoded by the MGMT (O6-methylguanine-DNA methyltransferase) gene in humans and is a key determinant of alkylating-agent chemotherapy response.
• Loss of this activity causes accumulation of O6-methylguanine, which mispairs with thymine and triggers G:C to A:T transition mutations.
• Research models for this activity include knockout, point-mutation, knock-in and overexpression cell lines, as well as biochemical methyltransferase assays.
Description
GO:0003908, methylated-DNA-[protein]-cysteine S-methyltransferase activity, is a molecular function that directly reverses a common form of DNA alkylation damage. The enzyme binds DNA containing 6-O-methylguanine and transfers the methyl group from the damaged base to a cysteine residue within its own active site, restoring the original guanine without excising the base or breaking the DNA backbone. This reaction is unusual because the protein acts as both the enzyme and the methyl acceptor, and it is consumed stoichiometrically, meaning each protein molecule can repair only one lesion. Because O6-methylguanine is a highly mutagenic and cytotoxic lesion, this activity is central to genome maintenance and to the cellular response to alkylating agents. Researchers study GO:0003908 to understand how cells resist alkylation damage, why some tumors respond poorly to alkylating chemotherapy, and how repair capacity can be measured or modulated experimentally. The activity is also relevant to mutagenesis, cancer predisposition, and the design of combination therapies that exploit repair deficiency.
methylated-DNA-[protein]-cysteine S-methyltransferase activity At A Glance
| GO ID | GO:0003908 |
|---|---|
| GO term | methylated-DNA-[protein]-cysteine S-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | 6-O-methylguanine-DNA methyltransferase activity; DNA-6-O-methylguanine:[protein]-L-cysteine S-methyltransferase activity; MGMT; O6-alkylguanine-DNA alkyltransferase; O-6-methylguanine-DNA-alkyltransferase activity |
| Major function | Direct reversal of O6-methylguanine DNA damage by transfer of the methyl group to a cysteine residue in the enzyme |
| Reaction | DNA (containing 6-O-methylguanine) + (protein)-L-cysteine = DNA (without 6-O-methylguanine) + protein S-methyl-L-cysteine |
| Cofactors | No exogenous cofactor required; the cysteine thiol acts as the methyl acceptor |
| Subcellular context | Nuclear and chromatin-associated in eukaryotic cells |
| Representative gene | MGMT (O6-methylguanine-DNA methyltransferase) in humans |
What Is GO:0003908?
In simple terms, this activity is a self-sacrificing DNA repair function that removes a methyl group from a damaged DNA base and attaches it to the repair protein itself. According to the QuickGO definition, it catalyzes the reaction: DNA (containing 6-O-methylguanine) + (protein)-L-cysteine = DNA (without 6-O-methylguanine) + protein S-methyl-L-cysteine. The enzyme recognizes O6-methylguanine in double-stranded DNA, flips the damaged base into its active site, and transfers the methyl group to a cysteine thiol, restoring guanine. Because the cysteine becomes methylated, the enzyme is inactivated after one turnover and must be degraded and resynthesized to sustain repair capacity.
Why Is methylated-DNA-[protein]-cysteine S-methyltransferase activity Important in Cell Biology?
GO:0003908 is important because it defines the only known direct reversal mechanism for O6-methylguanine, a lesion that is both mutagenic and cytotoxic. Without this activity, O6-methylguanine mispairs with thymine during replication, producing G:C to A:T transition mutations that can activate oncogenes or inactivate tumor suppressors. The activity also determines sensitivity to alkylating chemotherapeutic agents, and its regulation by phosphorylation and proteolysis directly affects how long a cell can sustain repair. Understanding this function therefore connects DNA repair biochemistry to cancer biology, drug resistance, and experimental strategies for measuring or manipulating repair capacity.
• Directly reverses O6-methylguanine, a major mutagenic lesion caused by alkylating agents.
• Prevents G:C to A:T transition mutations by restoring guanine before replication.
• Determines cellular sensitivity to alkylating chemotherapy and is a biomarker of response.
• Acts stoichiometrically, so repair capacity depends on protein levels and synthesis.
• Phosphorylation at serine-204 increases resistance to proteolytic digestion, linking signaling to repair.
• Loss of activity leads to mutation accumulation and genomic instability.
• Provides a target for experimental modulation in cancer and DNA repair research.
• Can be measured biochemically, enabling mechanistic studies of direct reversal repair.
Molecular Mechanism of methylated-DNA-[protein]-cysteine S-methyltransferase activity
Substrate recognition and base flipping
In simple terms: The enzyme finds the damaged base and flips it out of the DNA helix.
The methyltransferase scans double-stranded DNA for O6-methylguanine and, upon recognition, flips the damaged base out of the helix and into its active-site pocket. This base-flipping step positions the methyl group for nucleophilic attack by the active-site cysteine.
Methyl transfer to the active-site cysteine
In simple terms: The methyl group is moved from the DNA base onto the enzyme itself.
A cysteine thiol in the active site attacks the methyl group of O6-methylguanine, forming an S-methyl-L-cysteine and restoring guanine in the DNA. The reaction is a direct transfer with no free intermediate and no requirement for an exogenous cofactor.
Suicidal inactivation and protein turnover
In simple terms: Each enzyme molecule works only once and is then used up.
Because the methyl group remains covalently attached to the enzyme, the protein is inactivated after a single turnover. Continued repair therefore requires degradation of the methylated protein and synthesis of new enzyme, making the activity sensitive to protein stability and synthesis rates.
Regulation by phosphorylation and proteolysis
In simple terms: Chemical tags on the enzyme change how long it survives in the cell.
Phosphorylation of the methyltransferase at serine-204 significantly increases its resistance to proteolytic digestion, which can prolong its availability for repair. This post-translational modification links cellular signaling to the effective lifetime of the repair activity.
Biological consequence of the reaction
In simple terms: Repairing the damaged base prevents mutations and cell death.
By restoring guanine, the activity prevents O6-methylguanine from mispairing with thymine during replication, thereby avoiding G:C to A:T transition mutations. When the activity is absent or overwhelmed, persistent lesions cause mutations and cytotoxicity.
Key Genes Involved in GO:0003908 methylated-DNA-[protein]-cysteine S-methyltransferase activity
The following genes and proteins are directly or functionally associated with methylated-DNA-[protein]-cysteine S-methyltransferase activity and its study.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MGMT | Encodes the human O6-methylguanine-DNA methyltransferase that carries GO:0003908 activity | Central to alkylation repair, chemotherapy response and mutagenesis studies |
| AGT | Alternative name for the O6-alkylguanine-DNA alkyltransferase activity | Used in biochemical assays of direct reversal repair |
| Cysteine active-site residue | Acts as the methyl acceptor in the catalytic reaction | Target for point-mutation studies of catalysis |
| Serine-204 | Phosphorylation site that increases resistance to proteolytic digestion | Model for phospho-mimetic and phospho-null knock-in studies |
| Proteasome components | Mediate degradation of the inactivated, methylated enzyme | Relevant to regulation of repair capacity |
| DNA replication machinery | Converts unrepaired O6-methylguanine into mutations | Explains mutagenic consequences of lost activity |
| Mismatch repair proteins | Process O6-methylguanine mispairs and influence cytotoxicity | Linked to alkylating-agent sensitivity |
| Alkylating agent transporters | Determine intracellular exposure to alkylating drugs | Context for repair-capacity experiments |
| Transcription factors | Regulate MGMT expression | Relevant to overexpression and knockout models |
| Chromatin remodeling factors | Influence access of the repair enzyme to DNA | Studied in chromatin context |
| DNA damage sensors | Coordinate repair with cell cycle checkpoints | Connect GO:0003908 to stress responses |
| Apoptosis regulators | Determine cell fate after unrepaired alkylation damage | Used in cytotoxicity assays |
| Cell cycle kinases | Modulate phosphorylation of the methyltransferase | Relevant to serine-204 regulation |
| Ubiquitin ligases | Target the inactivated enzyme for degradation | Potential modulators of repair capacity |
| Housekeeping proteases | Contribute to turnover of the methyltransferase | Studied in proteolysis assays |
How Is methylated-DNA-[protein]-cysteine S-methyltransferase activity Regulated?
The activity is regulated at multiple levels. Because the enzyme is inactivated after a single methyl transfer, sustained repair depends on de novo synthesis and on the stability of the protein. Phosphorylation at serine-204 significantly increases resistance to proteolytic digestion, thereby extending the functional lifetime of the enzyme. Protein turnover pathways, including proteasomal degradation of the methylated protein, also control how quickly activity is lost and replenished. These regulatory features mean that measured activity reflects both gene expression and post-translational control.
methylated-DNA-[protein]-cysteine S-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MGMT | Alkylating-agent resistance and mutagenesis in cancer | MGMT knockout and overexpression cell lines |
| MGMT (S204) | Phosphorylation-dependent protein stability | S204A and S204D knock-in cell lines |
| MGMT (active-site cysteine) | Catalytic inactivation and suicidal repair | Cysteine-to-alanine point-mutation cell lines |
| MGMT | O6-methylguanine accumulation and G:C to A:T mutations | Reporter-based mutation assays in knockout cells |
| MGMT | Protein turnover and repair capacity | Tagged knock-in for degradation studies |
Cancer and alkylating-agent resistance
Loss or silencing of methylated-DNA-[protein]-cysteine S-methyltransferase activity increases sensitivity to alkylating agents because O6-methylguanine lesions persist and trigger cytotoxicity. Conversely, high activity contributes to resistance to alkylating chemotherapy. The activity is therefore a key determinant of treatment response in tumors exposed to alkylating drugs.
Mutagenesis and genomic instability
When the activity is absent, O6-methylguanine mispairs with thymine during replication, producing G:C to A:T transition mutations. This mutagenic signature can activate oncogenes or inactivate tumor suppressors, linking loss of GO:0003908 to genomic instability and cancer predisposition.
Cellular stress and proteolytic regulation
Phosphorylation at serine-204 increases resistance of the methyltransferase to proteolytic digestion, which can alter repair capacity under stress conditions. Dysregulation of this post-translational control may influence how cells cope with alkylation damage.
From methylated-DNA-[protein]-cysteine S-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GO:0003908 increase alkylation sensitivity? | MGMT knockout cell line |
| Is the active-site cysteine required for catalysis? | Point-mutation knock-in of cysteine to alanine |
| Does serine-204 phosphorylation affect protein stability? | Phospho-mimetic and phospho-null knock-in |
| Can repair capacity be increased by enzyme abundance? | MGMT overexpression cell line |
| How fast is the methylated enzyme degraded? | Tagged knock-in with degradation monitoring |
| Does the activity prevent G:C to A:T mutations? | Mutation reporter assay in knockout and wild-type cells |
How to Study the methylated-DNA-[protein]-cysteine S-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Methyltransferase activity assay | Direct transfer of methyl group from O6-methylguanine to protein | Quantifying GO:0003908 activity |
| Western blot | Protein levels of the methyltransferase | Assessing expression and stability |
| Proteolysis assay | Resistance of the enzyme to proteolytic digestion | Testing serine-204 phosphorylation effects |
| Mutation reporter assay | G:C to A:T transition frequency | Linking repair loss to mutagenesis |
| Cytotoxicity assay | Cell survival after alkylating-agent treatment | Measuring drug sensitivity |
| CRISPR knockout | Loss of gene function | Testing causal role of MGMT |
| CRISPR point mutation | Specific amino-acid substitution | Testing catalytic cysteine or serine-204 |
| Overexpression | Increased enzyme abundance | Testing repair capacity gain |
Biochemical methyltransferase assays
Direct measurement of GO:0003908 activity uses DNA substrates containing O6-methylguanine and detects transfer of the methyl group to the enzyme. These assays quantify repair capacity and can be combined with point-mutated enzymes to test catalytic requirements.
Western blotting and protein stability assays
Because the enzyme is inactivated after one turnover, protein levels and turnover are central to activity. Western blotting and proteolysis assays measure steady-state protein and resistance to digestion, including effects of serine-204 phosphorylation.
Mutation reporter and cytotoxicity assays
Reporter assays detect G:C to A:T transitions caused by unrepaired O6-methylguanine, while cytotoxicity assays measure sensitivity to alkylating agents. Together they link GO:0003908 to functional outcomes.
CRISPR-based genetic models
Knockout, point-mutation, knock-in and overexpression cell lines allow causal testing of the enzyme and its regulatory sites. These models are used to dissect repair capacity, drug response and mutagenesis.
How CRISPR Can Be Used to Study GO:0003908 methylated-DNA-[protein]-cysteine S-methyltransferase activity
Knockout
CRISPR knockout of MGMT eliminates GO:0003908 activity, producing cells that accumulate O6-methylguanine and show increased alkylating-agent sensitivity. These models are used to establish causality between the activity and DNA repair outcomes.
Point Mutation
Point mutations can substitute the active-site cysteine or serine-204 to test catalytic mechanism and phosphorylation-dependent stability. Such models distinguish catalytic function from regulatory control.
Knock-in
Knock-in of tagged or phospho-mimetic versions of the enzyme allows tracking of protein turnover and localization while preserving endogenous regulation. These models are valuable for studying the suicidal inactivation cycle.
Overexpression
Overexpression of MGMT increases repair capacity and can confer resistance to alkylating agents. It is used to test whether activity is limiting for damage tolerance.
How EDITGENE Supports methylated-DNA-[protein]-cysteine S-methyltransferase activity Research
Researchers studying methylated-DNA-[protein]-cysteine S-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in repair, mutagenesis or drug response. EDITGENE provides publication-ready CRISPR cell models and screening services to test these hypotheses directly.
Contact EDITGENE today to design your custom CRISPR model for methylated-DNA-[protein]-cysteine S-methyltransferase activity research.
Frequently Asked Questions About methylated-DNA-[protein]-cysteine S-methyltransferase activity
What is methylated-DNA-[protein]-cysteine S-methyltransferase activity?
It is a molecular function, GO:0003908, that removes a methyl group from O6-methylguanine in DNA and transfers it to a cysteine residue in the enzyme itself, directly restoring guanine.
What genes are involved in methylated-DNA-[protein]-cysteine S-methyltransferase activity?
The primary human gene is MGMT, which encodes the O6-methylguanine-DNA methyltransferase that carries this activity.
What is the reaction catalyzed by GO:0003908?
DNA containing 6-O-methylguanine plus a protein L-cysteine yields DNA without 6-O-methylguanine plus protein S-methyl-L-cysteine.
Why is this activity called suicidal?
Because the methyl group remains covalently bound to the enzyme, each protein molecule is inactivated after a single repair event.
How is this activity regulated?
It is regulated by protein synthesis and turnover, and phosphorylation at serine-204 increases resistance to proteolytic digestion.
What happens when this activity is lost?
O6-methylguanine persists, mispairs with thymine, and causes G:C to A:T transition mutations and increased sensitivity to alkylating agents.
How can I measure methylated-DNA-[protein]-cysteine S-methyltransferase activity?
Biochemical assays using O6-methylguanine-containing DNA measure direct methyl transfer, complemented by western blotting and mutation reporter assays.
What diseases are linked to this activity?
Loss or dysregulation is linked to mutagenesis, genomic instability and altered response to alkylating chemotherapy in cancer.
Can CRISPR be used to study this activity?
Yes, knockout, point-mutation, knock-in and overexpression models allow causal testing of the enzyme and its regulatory sites.
What model systems are used for GO:0003908 research?
Common models include MGMT knockout and overexpression cell lines, phospho-mutant knock-ins, and biochemical methyltransferase assays.
Conclusion
GO:0003908 defines a direct reversal DNA repair activity that removes O6-methylguanine by transferring its methyl group to a cysteine in the enzyme. This self-sacrificing mechanism protects cells from mutations and determines sensitivity to alkylating agents, with regulation by phosphorylation and protein turnover. Studying this activity with CRISPR knockout, point-mutation, knock-in and overexpression models provides causal insight into DNA repair, mutagenesis and cancer therapy response.
References
- 1. Lim IK et al.. 2000. Phosphorylation of methylated-DNA-protein-cysteine S-methyltransferase at serine-204 significantly increases its resistance to proteolytic digestion.. Biochem J 352 Pt 3(Pt 3):801-8 PMID: 11104689
